Clinical Trials

Showing 481 - 500 of 513 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Carfilzomib in Patients with Previously Treated Systemic Light Chain Amyloidosis
[Protocol 12-276]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of Carboxyamidotriazole Orotate Plus Temozolomide in Patients with Glioblastoma Multiforme and Other Recurrent Malignant Gliomas
[Protocol 12-007]
Omuro, Antonio
  • Brain Tumors, Primary
    • Gliomas
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 09-106]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
Relapsed/Refractory
[Protocol 13-021]
Trippett, Tanya
  • Pediatric Brain Tumors
    • CNS Cancer
  • Primary Bone
  • Sarcomas
  • Solid Tumors
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027]
Dickler, Maura
  • Breast Cancer
A Phase I Study of BVD-523 in Patients with Advanced Cancers
[Protocol 13-254]
Varghese, Anna
  • Melanoma
  • Solid Tumors
A Phase I Study of Brentuximab Vedotin plus Temsirolimus in Relapsed and Refractory Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 13-044]
Moskowitz, Alison
  • Lymphoma
    • Hodgkin's Disease
A Phase I Study of Brentuximab Vedotin for Acute Graft-vs-Host Disease that Persists Despite Steroids
[Protocol 13-232]
Perales, Miguel-Angel
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
A Phase I Study of BMS-986016 Alone and with Nivolumab in Patients with Advanced Solid Tumors
[Protocol 14-010]
Callahan, Margaret
  • Solid Tumors
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Solid Tumors
A Phase I Study of BMS-906024 in Adult and Pediatric Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
Relapsed/Refractory
[Protocol 11-181]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of BKM120 with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 10-192]
Fury, Matthew
A Phase I Study of BKM120 and Olaparib in Patients with High-Grade Serous Ovarian Cancer
[Protocol 12-233]
Bell-McGuinn, Katherine
  • Breast Cancer
  • Ovarian Cancer
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
Relapsed/Refractory
[Protocol 12-151]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of AZD5363 in Patients with Solid Tumors Who Have AKT1 and PI3KCA Mutations
[Protocol 14-214]
Hyman, David
  • Solid Tumors
A Phase I Study of ASP8273 in Patients with Non-Small Cell Lung Cancer and EGFR Mutations
[Protocol 14-128]
Yu, Helena
  • Lung Cancer, Non-Small Cell
A Phase I Study of ASG-22CE in Patients with Metastatic Urothelial Cancers Containing Nectin-4
[Protocol 14-108]
Rosenberg, Jonathan
  • Bladder Cancer
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049]
Dickler, Maura
  • Breast Cancer
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Multiple Myeloma as Consolidation Treatment after Autologous Stem Cell Transplantation
[Protocol 13-009]
Chung, David
  • Hematology
    • Multiple Myeloma